Exploring the Utilization of Effective Combination Therapy with the Right Diagnostic Tool to Optimize the Management of the NASH Population

Time: 1:30 pm
day: Seminar B PM tracks


  • Outlining the steps needed to ensure the management of patients is improved following drug approval
  • Understanding how combination therapy could affect real world settings to prevent rebounds
  • Strengthening the synergy between pharma and biotech to increase investments and awareness of the management journey for patients